Article info
PDFLetter
Tofacitinib for the treatment of antineutrophil cytoplasm antibody-associated vasculitis: a pilot study
- Correspondence to Dr Lindi Jiang, Department of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai 200032, China; zsh-rheum{at}hotmail.com
Citation
Tofacitinib for the treatment of antineutrophil cytoplasm antibody-associated vasculitis: a pilot study
Publication history
- Received March 31, 2021
- Accepted July 27, 2021
- First published August 6, 2021.
Online issue publication
April 04, 2023
Article Versions
- Previous version (7 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.